Mwandishi
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
19 Februari 2026, 15:18:39
Vitamin B6/Pyridoxine Deficiency
Vitamin B6 (pyridoxine) deficiency is a nutritional disorder caused by inadequate levels of pyridoxine or its active metabolite pyridoxal-5-phosphate (PLP) — an essential coenzyme in amino-acid metabolism, neurotransmitter synthesis, hemoglobin formation, and immune function.
Deficiency primarily affects tissues with high metabolic demand such as:
Peripheral nerves
Skin
Brain
Bone marrow
Clinically, it commonly presents with neurological and hematological manifestations, especially peripheral neuropathy and sideroblastic anemia.
2. Physiology and Pathophysiology
Normal Functions of Vitamin B6
Pyridoxine acts as a cofactor in:
System | Function |
Nervous system | Synthesis of serotonin, dopamine, GABA |
Hematologic | Heme synthesis |
Metabolic | Amino acid metabolism & gluconeogenesis |
Immune | Lymphocyte proliferation |
Skin | Keratin formation |
Mechanism of Disease
Deficiency leads to:
↓ Neurotransmitter synthesis → neuropathy, seizures
↓ Heme synthesis → sideroblastic anemia
↑ Homocysteine → vascular risk
Impaired tryptophan metabolism → dermatitis & glossitis
Isoniazid toxicity mechanism:Isoniazid binds pyridoxine → inactive hydrazone complex → functional deficiency.
3. Risk Factors
Nutritional
Severe malnutrition
Elderly with poor diet
Chronic illness
Pregnancy
Exclusive polished-rice diets
Drug-Induced
Isoniazid (most common cause worldwide)
Penicillamine
Cycloserine
Oral contraceptives
Levodopa without carbidopa
Disease-Associated
Chronic alcoholism
Chronic kidney disease
HIV infection
Malabsorption syndromes
Post-bariatric surgery
4. Clinical Features
Early Symptoms
Irritability
Fatigue
Cheilosis
Glossitis
Seborrheic dermatitis
Neurological Manifestations
Tingling sensation
Burning pain in feet
Numbness
Peripheral neuropathy
Seizures (infants)
Depression
Confusion
Hematological Manifestations
Microcytic sideroblastic anemia
Pallor
Weakness
Dermatological Manifestations
Angular stomatitis
Glossitis
Dermatitis (seborrheic type)
Severe Deficiency
Encephalopathy
Optic neuropathy
Ataxia
5. Diagnostic Criteria
Diagnosis is based on clinical suspicion + laboratory confirmation.
Suggestive when patient has:
Peripheral neuropathy AND
Risk factor (especially TB therapy) AND
Response to pyridoxine treatment
6. Investigations
Laboratory Tests
Test | Expected Finding |
Plasma pyridoxal-5-phosphate | Low (<20 nmol/L) |
CBC | Microcytic or sideroblastic anemia |
Homocysteine | Elevated |
Iron studies | High ferritin |
Bone marrow | Ring sideroblasts (rarely needed) |
Differential Diagnoses
Vitamin B12 deficiency
Diabetic neuropathy
Alcoholic neuropathy
Hypothyroidism
Heavy metal poisoning
7. Management
A. Non-Pharmacological
Lifestyle
Stop alcohol use
Nutritional rehabilitation
Manage malabsorption disorders
Dietary Advice
Increase intake of pyridoxine-rich foods:
Liver, meat, fish and offal
Wholegrain cereals and fortified breakfast cereals
Peanuts and bananas
Raw vegetables
Walnuts and seeds
Avocados and dried fruits
Potatoes and baked beans
B. Pharmacological Treatment
i. Treatment of Deficiency
Children
Pyridoxine 12.5 mg PO daily × 3 weeks
Adults
Pyridoxine 25 mg PO daily × 3 weeks
ii. Drug-Induced Neuropathy (e.g., Isoniazid)
Children
Pyridoxine 50 mg PO daily × 3 weeks
Adults
Pyridoxine 200 mg PO daily × 3 weeks
iii. Maintenance (for TB therapy)
Pyridoxine 25 mg PO daily
4. Acute Neurotoxicity or Seizures (Emergency)
Pyridoxine IV 50–100 mg immediately(especially in INH overdose)
8. Monitoring and Follow-Up
Parameter | Frequency |
Neuropathy symptoms | Weekly |
Hemoglobin | Monthly |
TB patients | At each visit |
Nutritional status | Monthly |
Improvement usually begins within 1–2 weeks, but neuropathy may take months to recover.
9. Complications if Untreated
Permanent neuropathy
Chronic pain syndrome
Seizure disorder in infants
Severe anemia
Cognitive impairment
10. Prevention
High-Risk Groups (MUST receive prophylaxis)
All TB patients on isoniazid
Alcohol use disorder
Malnourished patients
HIV patients
Pregnant women on TB therapy
Recommended prophylaxis dose
Pyridoxine 10–25 mg daily
11. Prognosis
Excellent if treated early
Neuropathy reversible in early stages
Late treatment → permanent nerve damage
References
World Health Organization. Guideline: vitamin and mineral requirements in human nutrition. 2nd ed. Geneva: WHO; 2004.
National Institutes of Health Office of Dietary Supplements. Vitamin B6 fact sheet for health professionals. Bethesda: NIH; 2023.
Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12. Washington DC: National Academy Press; 1998.
Langan RC, Zawistoski KJ. Update on vitamin B6 deficiency. Am Fam Physician. 2011;83(10):1195-9.
O’Leary F, Samman S. Vitamin B6 in health and disease. Nutrients. 2010;2(8):859-71.
StatPearls Publishing. Pyridoxine deficiency. Treasure Island (FL): StatPearls; 2024.
Centers for Disease Control and Prevention. Treatment of tuberculosis: guidelines. Atlanta: CDC; 2022.
British National Formulary (BNF). Pyridoxine hydrochloride monograph. London: BMJ Group and Pharmaceutical Press; 2024.
Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Anastasi J, Weitz J. Hematology: basic principles and practice. 7th ed. Philadelphia: Elsevier; 2018.
Murray RK, Bender DA, Botham KM, Kennelly PJ, Rodwell VW, Weil PA. Harper’s illustrated biochemistry. 32nd ed. New York: McGraw-Hill; 2021.
